NRIX
Nurix Therapeutics Inc
23.00$
-2.7%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 86.9% | 83.1% | 80.3% | 88.1% | 88.8% | 92.5% | 91.7% | 87.1% | 84.3% | 88.2% | 87.2% | 85.2% | |
| 13.7% | 15.4% | 15.9% | 22.9% | 19.3% | 16.4% | 12.3% | 14.2% | 15.0% | 35.9% | 11.2% | 12.6% | |
| 84.0% | 81.0% | 78.0% | 86.7% | 87.2% | 91.1% | 89.4% | 82.1% | 82.1% | 86.2% | 85.0% | 82.8% | |
| 0.6% | 0.2% | 0.3% | 0.1% | 0.2% | 0.2% | 1.5% | 3.2% | 0.3% | – | 0.4% | – | |
| 0.0% | – | – | – | -0.2% | – | – | – | – | – | – | – | |
| 8.3% | – | – | – | – | – | – | – | – | – | – | – | |
| 24.1% | 43.6% | 46.0% | 27.5% | 26.6% | 21.3% | 21.8% | 24.3% | 28.8% | 21.7% | 24.4% | 24.8% | |
| 20.0% | 24.5% | 28.0% | 15.8% | 16.8% | 14.3% | 14.6% | 12.8% | 15.8% | 12.6% | 14.5% | 13.4% | |
| 1.7% | 2.1% | 2.3% | 1.6% | 1.3% | 1.2% | 1.1% | 0.9% | 0.7% | 0.4% | 0.5% | 0.6% | |
| 0.7% | 1.8% | 1.9% | 0.6% | 0.8% | 1.7% | 1.4% | 1.0% | 1.6% | 1.6% | 1.6% | 2.3% | |
| 75.9% | 56.4% | 54.0% | 72.5% | 73.4% | 78.7% | 78.2% | 75.7% | 71.2% | 78.3% | 75.6% | 75.2% | |
| -163.3% | -153.3% | -187.6% | -123.5% | -132.4% | -110.4% | -129.3% | -141.8% | -177.0% | -145.8% | -171.4% | -220.3% | |
| 17.6% | 15.4% | 17.6% | 12.2% | 14.2% | 11.7% | 13.6% | 14.2% | 16.1% | 13.8% | 17.3% | 20.7% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.